A decreased level of high‐density lipoprotein is a possible risk factor for type 2 diabetes mellitus: A review

A decreased level of high‐density lipoprotein is a possible risk factor for type 2 diabetes mellitus: A review

Abstract Introduction Type 2 diabetes mellitus (T2DM) is characterized primarily by dyslipidemia and hyperglycemia due to insulin resistance. High‐density lipoprotein (HDL) play a significant role in preventing the incidence of dyslipidemia and its complications. HDL has different protective functio...

Full description

Bibliographic Details
Main Authors:	Ali Bayat Bodaghi, Erfan Ebadi, Mohammad Javad Gholami, Reza Azizi, Aref Shariati
Format:	Article
Language:	English
Published:	Wiley 2023-12-01
Series:	Health Science Reports
Subjects:	apo A‐I diabetes high‐density lipoproteins prevention
Online Access:	https://doi.org/10.1002/hsr2.1779

Similar Items

A case report of youth-onset lipoprotein glomerulopathy with APOE Chicago mutation
by: Yuhao Liu, et al.
Published: (2024-03-01)

Construction and application of artificial lipoproteins using adiposomes
by: Zhen Cao, et al.
Published: (2023-10-01)

Clinical and genetic analysis of lipoprotein glomerulopathy patients caused by APOE mutations
by: Mingxin Yang, et al.
Published: (2020-08-01)

SPECIFICS OF SUBFRACTIONAL SPECTRUM OF APOLIPOPROTEIN B RELATED LIPOPROTEINES IN CAROTID OR CORONARY ATHEROSCLEROSIS PATIENTS
by: N. E. Gavrilova, et al.
Published: (2016-10-01)

Cysteamine Decreases Low‐Density Lipoprotein Oxidation, Causes Regression of Atherosclerosis, and Improves Liver and Muscle Function in Low‐Density Lipoprotein Receptor–Deficient Mice
by: Feroz Ahmad, et al.
Published: (2021-09-01)

Improved isolation of extracellular vesicles by removal of both free proteins and lipoproteins
by: Dmitry Ter-Ovanesyan, et al.
Published: (2023-05-01)

Physiological Bases for the Superiority of Apolipoprotein B Over Low‐Density Lipoprotein Cholesterol and Non–High‐Density Lipoprotein Cholesterol as a Marker of Cardiovascular Risk
by: Tamara Glavinovic, et al.
Published: (2022-10-01)

Structural and Functional Impairments of Reconstituted High-Density Lipoprotein by Incorporation of Recombinant β-Amyloid42
by: Kyung-Hyun Cho
Published: (2021-07-01)

NMR-Based Analysis of Plasma Lipoprotein Subclass and Lipid Composition Demonstrate the Different Dietary Effects in ApoE-Deficient Mice
by: Cheng-Hung Yang, et al.
Published: (2024-02-01)

Decreased Efficiency of Very-Low-Density Lipoprotein Lipolysis Is Linked to Both Hypertriglyceridemia and Hypercholesterolemia, but It Can Be Counteracted by High-Density Lipoprotein
by: Ewa Wieczorek, et al.
Published: (2021-04-01)

SUBFRACTION DISTRIBUTION OF APO B-CONTAINING LIPOPROTEINS DEPENDING ON THE ACHIEVEMENT OF THE TARGET LEVEL OF LOW DENSITY LIPOPROTEINS UNDER STATINS THERAPY IN PATIENTS WITH CORONARY ATHEROSCLEROSIS
by: I. N. Ozerova, et al.
Published: (2017-12-01)

Lipoprotein(a) Where Do We Stand? From the Physiopathology to Innovative Terapy
by: Gabriella Iannuzzo, et al.
Published: (2021-07-01)

Clinicopathological characteristics and gene mutations in 11 patients with lipoprotein glomerulopathy
by: Yan Qin, et al.
Published: (2024-12-01)

Small dense low-density lipoprotein cholesterol compared to other lipoprotein biomarkers for predicting coronary heart disease among individuals with normal fasting glucose: The Multi-Ethnic Study of Atherosclerosis
by: Sarah O. Nomura, et al.
Published: (2023-03-01)

Lipoprotein Glomerulopathy, First Case Report from Canada
by: Ting JA, et al.
Published: (2022-06-01)

Lipoprotein(a) Lowering—From Lipoprotein Apheresis to Antisense Oligonucleotide Approach
by: Maria Francesca Greco, et al.
Published: (2020-07-01)

Contemporary patterns of lipoprotein(a) testing and associated clinical care and outcomes
by: Michelle D. Kelsey, et al.
Published: (2023-06-01)

Association of candidate genetic variants and circulating levels of ApoE/ApoJ with common neuroimaging features of cerebral amyloid angiopathy
by: Anna Bonaterra-Pastra, et al.
Published: (2023-04-01)

Apoprotein (a) isoforms: a link with quantitative levels of lipoprotein(a), aspects of multi-stage atherogenicity and other apo (a) correlations
by: A. V. Tikhonov, et al.
Published: (2012-06-01)

apoB/apoA‐I Ratio and Lp(a) Associations With Aortic Valve Stenosis Incidence: Insights From the EPIC‐Norfolk Prospective Population Study
by: Kang H. Zheng, et al.
Published: (2019-08-01)

An Efficacy of Seligi Leaf Flour Fermentation on Cholesterol Levels, Low Density Lipoprotein, and High Density Lipoprotein in Catfish
by: Reza Hardiansyah, et al.
Published: (2022-04-01)

High-density lipoproteins : from basic biology to clinical aspects /
by: Fielding, Christopher J.
Published: (2007)

Lipoprotein (a), Inflammation, and Atherosclerosis
by: Stefania Angela Di Fusco, et al.
Published: (2023-03-01)

Inclisiran, Low-Density Lipoprotein Cholesterol and Lipoprotein (a)
by: Niki Katsiki, et al.
Published: (2023-04-01)

Human plasma lipoproteins /
by: Fruchart, J. C., et al.
Published: (1989)

Lipoprotein(a) Testing Trends in a Large Academic Health System in the United States
by: Harpreet S. Bhatia, et al.
Published: (2023-09-01)

High Density Lipoproteins and Diabetes
by: Blake J. Cochran, et al.
Published: (2021-04-01)

High density lipoproteins and atherosclerosis II /
by: International Symposium on High Density Lipoproteins and Atherosclerosis (2nd : 1988 : Maidstone, England), et al.
Published: (1989)

High-Density Lipoprotein and Heart Failure
by: Liyun Xing, et al.
Published: (2023-11-01)

Normal and reconstituted high-density lipoprotein protects differentiated monocytes from oxidized low-density lipoprotein-induced apoptosis
by: Navkiran Kaur, et al.
Published: (2020-10-01)

High-Density Lipoprotein Suppresses Neutrophil Extracellular Traps Enhanced by Oxidized Low-Density Lipoprotein or Oxidized Phospholipids
by: Hitomi Ohinata, et al.
Published: (2022-11-01)

Lipoprotein(a) Serum Levels Predict Pulse Wave Velocity in Subjects in Primary Prevention for Cardiovascular Disease with Large Apo(a) Isoforms: Data from the Brisighella Heart Study
by: Arrigo F. G. Cicero, et al.
Published: (2022-03-01)

The chylomicron saga: time to focus on postprandial metabolism
by: Alejandro Gugliucci
Published: (2024-01-01)

Lipoprotein(a) in the Evaluation of Cardiovascular Risk in the Portuguese Population
by: Joaquim A. Meireles-Brandão, et al.
Published: (2019-03-01)

THE ROLE OF LIPOPROTEIN(A) IN CARDIOVASCULAR DISEASES IN CHILDREN AND ADOLESCENTS
by: Alina-Costina LUCA, et al.
Published: (2016-07-01)

Target Low-Density Lipoprotein-Cholesterol and Secondary Prevention for Patients with Acute Myocardial Infarction: A Korean Nationwide Cohort Study
by: Ju Hyeon Kim, et al.
Published: (2022-05-01)

Mathematical Modelling of Material Transfer to High-Density Lipoprotein (HDL) upon Triglyceride Lipolysis by Lipoprotein Lipase: Relevance to Cardioprotective Role of HDL
by: Svetlana Schekatolina, et al.
Published: (2022-07-01)

Lipoprotein(a): Evidence for Role as a Causal Risk Factor in Cardiovascular Disease and Emerging Therapies
by: Harpreet S. Bhatia, et al.
Published: (2022-10-01)

Apolipoprotein B - An ideal biomarker for atherosclerosis?
by: Kavita Singh, et al.
Published: (2024-03-01)

A guidebook to lipoprotein technique /
by: 439775 Mills, G. L., et al.
Published: (1984)